69097-805 : Azacitidine for for 100 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution


NDC: 69097-805
Labeler: Cipla USA Inc.
Product Type: Human Prescription Drug
Drug Name:  Azacitidine for
Dosage Form: Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution
Application #: ANDA207518
Rev. Date: 


NDC Package Codes:

  • 69097-805-40: 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION IN 1 CARTON (69097‑805‑40)

Active Ingredients:

  • Azacitidine

Dosage Strength:

  • 100 mg

Pharmaceutical Classes:

  • Nucleic Acid Synthesis Inhibitors [MoA]
  • Nucleoside Metabolic Inhibitor [EPC]

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 69097-805 QR Code

< Prev: 69097-802Next: 69097-807 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.